Tag Archives: NASDAQ:ALXA

Healthcare Sector Summary: Alexza Pharmaceuticals (NASDAQ:ALXA), Metabolix (NASDAQ:MBLX) – ALXA, MBLX, SHLM, CADX, PGNX, RPRX

Investors reacted positively to the healthcare stocks on Tuesday. Major movement were observed in Cadence Pharmaceuticals, Inc (NASDAQ:CADX) and Progenics Pharmaceuticals, Inc (NASDAQ:PGNX) on percentage gainers side while Repros Therapeutics Inc (NASDAQ:RPRX) was prominent stock on the losers side.

Alexza …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , | Comments Off

Alexza Pharmaceuticals (NASDAQ:ALXA) Wins Approval for Adasuve by FDA – ALXA, SOMX, TSPT, XNPT

Alexza Pharmaceuticals, Inc (NASDAQ:ALXA) reported on Saturday that the United States Food and Drug Administration approved its schizophrenia and bipolar disorder treatment Adasuve, one more latest win for the Mountain View, California based small drug manufacturer.

The medicine was approved …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , | Comments Off

Pernix Therapeutics (NYSE:PTX) To Acquire Somaxon (SOMX); $25 Million Accord – PTX, CRME, DEPO, AGN, DVAX, AMRN, ALXA, PFE, JNJ

Pernix Therapeutics Holdings Inc (NYSE:PTX) reported on Tuesday that it is purchasing Somaxon Pharmaceuticals, Inc (NASDAQ:SOMX) in a stock-for-stock agreement, worth at $25 million.

The Woodlands, Texas based Pernix anticipates to benefit from Somaxon’s insomnia drug Silenor in the purchase, …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Questcor Pharmaceuticals (NASDAQ:QCOR) Plans to Market Acthar; Stock Boosts – QCOR, SOMX, MYL, ALXA

The Anaheim, California based Questcor Pharmaceuticals, Inc (NASDAQ:QCOR) stock moved up on Friday after the corporation reported aims to promote its drug Acthar as a treatment for rheumatology conditions.

Questcor reported after the markets closed on Thursday that it would …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , | Comments Off

Alexza (NASDAQ:ALXA) New Drug Application unaccepted, AMN (NYSE:AHS) Reports Results- ALXA, AHS, CFN, SQNM, HLF, LLY, BMY

Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA) announced on Friday its new drug application for Adasuve, a schizophrenic and bipolar disorder treatment, cannot be permitted by the US Food and Drug Administration until a deficiency at a manufacturing facility for the application is …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , | Comments Off

Most Worse Momentum at Healthcare Sector, Shares Plunges More Than 20%- SGYP, ALXA, AMRN, WCRX, TEVA, RDEA, AGN

Shares of Synergy Pharmaceuticals (SGYP) go into the chasm, after the pharma’s reported that it plans to offer 10 million common stock shares to finance its research and development activities, which comprise clinical trials of its plecanatide and SP-333 treatments …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , | Comments Off